Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEOGLI
2014-003436-39Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of glibenclamide in Neonatal diabetes mellitus (NDM), sponsored by Assistance publique - Hôpitaux de Paris. Started Aug 2015; status: completed.
02
Drugs
glibenclamide
03
Conditions
Neonatal diabetes mellitus (NDM)
Beyond the preview
Go deeper on 2014-003436-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003436-39.